Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.

By Francesco Sardanelli, C. Boetes, B. Borisch, T. Decker, M. Federico, F. Gilbert, T. Helbich, S. Heywang-Köbrunner, W. Kaiser, M. Kerin and 13 more. European Journal of Cancer, 2010

954 citations recorded by the source corpus.

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point.

Subfields: Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/7fcfd6603f2382e166238145c6eebf4cde6cb30a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

F. Penault-Llorca
E. Senkus
F. Cardoso
R. Mann
P. Poortmans
S. Kyriakides
N. Cho
S. Ohno

Citations in the corpus

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, background): “Magnetic resonance imaging (MRI) of the breast is not needed as a routine procedure, but may be considered in cases involving diagnostic challenges arising, for example, because of dense breast tissue especially in young women, in cases of familial breast cancer associated with BRCA mutations, silic”
Breast MRI: State of the Art. (2019, background): “However, mucinous carcinoma, necrotic cancer, and metaplastic carcinoma can have high signal intensity on T2-weighted images (2).”